2 Microcap COVID-19 Growth Stocks With "Buy" Ratings From Analysts

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga.

As the world begins to embrace the “new normal,” some companies and their respective industries will not survive. The unprecedented economic impact of the “Great Lockdown” will continue to be felt for some time.

For some industries, the “changing of the guard” was just what was needed to re-awaken growth. Others like technology, which already had a strong outlook prior to the outbreak, could see even greater demand and attention as society adapts. 

According to the Pew Research Center, 53% of Americans surveyed said that the internet has been essential to them during the lockdown. The pandemic has expanded our digital lives and made our reliance on the internet much more pronounced. From ordering essential items and groceries to telehealth appointments and Zoom conferences, technology continues to be a key area of growth.

Mohawk Group Holdings, Inc. MWK and Intellicheck, Inc. IDN are two microcap technology stocks that have seen strong growth during the COVID-19 pandemic and also have strong support from analysts.

Mohawk Group

Mohawk is a technology-enabled consumer packaged goods company, which utilizes its proprietary artificial intelligence platform, AIMEE, to help locate emerging trends within the consumer goods arena. Currently, Mohawk has five active e-commerce brands, after recently launching its latest, Holonix, which will focus on personal protective equipment and wellness products.

Despite COVID-19, Mohawk has steadily seen expanding growth and sales over the past several months. Just recently, the company disclosed that preliminary May 2020 net revenues increased by approximately 105% compared to the same period in 2019.

As a result of the continued strong growth and results, management increased its full-year 2020 outlook, which now estimates net revenues to come between $170 million and $180 million. Furthermore, Mohawk now estimates to report positive adjusted EBITDA during the second quarter of 2020, compared to original estimates of later in 2020. 

Mohawk Group’s growth has not gone unnoticed with analysts. According to TipRanks, there are currently four analysts covering Mohawk. All four have a “buy” rating on Mohawk and list price targets in a range between $8.00 and $12.00. Assuming a conservative average price target of $8.50 from the analysts, which implies a 66.67% upside from current levels. 

Mohawk’s five-star analyst, Tom Forte of D.A. Davidson, has a price target for Mohawk set at $9.00, which gives further upside potential to over 76%. According to Forte, revenue could grow by 36.7% per year from 2019-2022, and its EBITDA margin could expand from 16.2% to this year.

The company’s most bullish analyst is Brian Kinstlinger of Alliance Global Partners, who holds a $12 price target, which represents over 135% upside from current pricing. 

Intellicheck

Intellicheck, Inc. is focused on developing and marketing technology solutions that help stop fraud and identity theft. Through the company’s proprietary technology, Intellicheck aims to stop digital fraud by implementing real-time identification authentication and age verification services. 

The company says that its technology helps companies improve operational efficiencies, as well as revenues, customer service, etc. Currently, Intellicheck is working with banks, financial institutions, retailers, government agencies, and defense companies to implement its technological safeguards.

In late June 2020, the company announced that “a top financial institution” signed an agreement with Intellicheck to implement its anti-fraud protections. Although the institution could not be named presumably due to the nature of their agreement, management did note that the bank is Midwest-based and has around 1,200 branches across 26 different states.

Bank tellers at this Midwest bank will now be equipped with tablets outfitted with Intellicheck’s authentication technology to approve IDs in real-time, accelerate financial transactions, and maintain AML/KYC compliance.  

According to TipRanks, Intellicheck currently has four analysts covering its stock, with three "buy" ratings and one "hold" rating. Currently, the analysts have an average price target of $11.00 for the company, which implies a potential upside of over 38% from current levels.  

Just two weeks ago, four-and-a-half-star analyst, Michael Grondahl of Northland Securities, placed a “buy” rating on Intellicheck with a price target of $10.00. The company’s most bullish analyst, Scott Buck of B.Riley, maintains a "buy" rating and a $12.00 price target, which implies an upside of nearly 51% from current levels.

Disclaimer:

Spotlight Growth is compensated, either directly or via a third party, to provide investor relations services for its clients. Spotlight Growth creates exposure for companies through a customized marketing strategy, including design of promotional material, the drafting and editing of press releases and media placement.

All information on featured companies is provided by the companies profiled, or is available from public sources. Spotlight Growth and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on external sources that Spotlight Growth believes to be reliable, but its accuracy is not guaranteed. Spotlight Growth may create reports and content that has been compensated by a company or third-parties, or for purposes of self-marketing. Spotlight Growth was compensated five thousand dollars by Mohawk for the creation and dissemination of this content by the company.

This material does not represent a solicitation to buy or sell any securities. Certain statements contained herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company’s plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company’s industry, management’s beliefs and certain assumptions made by management.

The above communication, the attachments and external Internet links provided are intended for informational purposes only and are not to be interpreted by the recipient as a solicitation to participate in securities offerings.  Investments referenced may not be suitable for all investors and may not be permissible in certain jurisdictions.

Spotlight Growth and its affiliates, officers, directors, and employees may have bought or sold or may buy or sell shares in the companies discussed herein, which may be acquired prior, during or after the publication of these marketing materials. Spotlight Growth, its affiliates, officers, directors, and employees may sell the stock of said companies at any time and may profit in the event those shares rise in value. For more information on our disclosures, please visit: https://spotlightgrowth.com//disclosures/

The preceding post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Although the piece is not and should not be construed as editorial content, the sponsored content team works to ensure that any and all information contained within is true and accurate to the best of their knowledge and research. This content is for informational purposes only and not intended to be investing advice.